ABSTRACT
The study and analysis of glaucoma epidemiology is fundamental in order for relevant, timely and efficient therapy to be realized. Proper screening is still hampered by inadequate methods for both detecting and treating the disease and a lack of a consensus on well-defined standardized diagnostic screening criteria. Once established, the generation
of additional, sufficient data would offer more comprehensive, tangible results for prevention and treatment of this visually threatening disease. The incidence of disease would be more accurately foreseen and risk factors delineated.
